Salmonella non typhoidique : une cause rare d'infection urinaire

Le but de notre travail est d'analyser les aspects cliniques; bacteriologiques et therapeutiques des infections urinaires a Salmonella non typhi (SNT) dans notre region. Patients et methodes : Il s'agit d'une etude descriptive retrospective ayant concerne les cas d'infections urinaires a SNT diagnostiques a l'hopital Sahloul (Sousse; Tunisie) recenses sur une periode de six ans et demi (Janvier 2003-Juin 2009). Les souches ont ete identifiees grace a leurs caracteres morphologiques; biochimiques et antigeniques. Un antibiogramme a ete effectue. Resultats : 9 cas d'infection urinaire a SNT ont ete ainsi recenses; soit 0;079des infections urinaires colligees au laboratoire de microbiologie durant la meme periode. L'age moyen des patients etait de 45 ans. Un terrain debilite etait note chez 8 des 9 patients. Les facteurs favorisants notes etaient variables et parfois associes chez un meme patient: diabete (4 cas); traitement corticoide et immunosuppresseur (3 cas); insuffisance renale (3 cas); reflux vesico-uretral (1 cas); pathologie tumorale (4 cas); lupus erythemateux systemique (1 cas); hypertrophie prostatique (1 cas). Les serotypes notes etaient Salmonella enteritidis (8 cas); Salmonella typhimurium (1 cas). L'evolution sous antibiotherapie adaptee (duree moyenne de 16.4 jours) etait favorable dans 7 cas. Conclusion : L'infection urinaire a SNT survient en regle sur un terrain predispose notamment un diabete sucre; une uropathie ou un etat d'immunodepression. Le traitement antibiotique doit etre suffisamment prolonge pour eviter les complications et les recidives

Successful Treatment of Homozygous Cystinuria with Captopril

Objective : Cystinuria is an autosomal recessive hereditary disorder associated with nephrolithiasis and its attendant complications. Traditional management using oral alkali; D-penicillamine; or mercaptopropionyglycine in an attempt to increase urinary cystine solubility is often unsuccessful due to intolerable side-effects. The aim of this study was to determine; if captopril could reduce urinary cystine excretion in homozygous cystinuric patients. Patients and methods : Three cystinuric patients with a history of multiple cystine stones despite previous traditional therapy were treated with 150 mg captopril daily for 3 years after determination of their baseline 24-hour urine cystine excretion. Cystine excretion studies were repeated subsequently at 6-month intervals. Results : The baseline 24-hour urine cystine excretion was within the expected limits for homozygous cystinuria in all patients (1072; 862 and 959 mg cystine per gm creatinine per 24 hours). After institution of captopril treatment; all patients had a significant decrease in urinary cystine levels (374; 313 and 451 mg cystine per gm creatinine per 24 hours). No patient experienced recurrent nephrolithiasis or adverse drug effects. Conclusion : We conclude that captopril can significantly decrease urinary cystine excretion in patients with homozygous cystinuria. Captopril should be considered an alternative to traditional drug management of cystinuria